VAXSAFE RIS VACCINE (LIVING)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
MAREK'S DISEASE
Available from:
BIOPROPERTIES PTY LTD
INN (International Name):
MDV (CVI 988)
Pharmaceutical form:
MISC. VACCINES OR ANTI SERA
Composition:
MAREK'S DISEASE VACCINE-GENERAL Active 0.0 P
Units in package:
1000 Doses; 2000 Doses; 3000 Doses; 4000 Doses; Vials
Class:
VM - Veterinary Medicine
Therapeutic group:
POULTRY | BREEDERS | BROILER | CHICKENS | CHICKS | CHOOKS | DAY OLD CHICKS | HATCHLINGS | LAYERS
Therapeutic area:
IMMUNOTHERAPY
Therapeutic indications:
VACCINE | EQUINE ROTAVIRUS
Product summary:
Poison schedule: 0; Withholding period: WHP: Nil.; Host/pest details: POULTRY: [VACCINE]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY: [VACCINE]; For the prevention of virulent Marek's disease in chickens.This product is contraindicated for vaccinating unhealthy birds.
Authorization status:
Registered
Authorization number:
50485
Authorization date:
2018-07-01

Vaxsafe

RIS Vaccine (living)

50485_40045_1000d_Label_MPL_V1

Page 1 of 1

FOR ANIMAL TREATMENT ONLY

Vaxsafe

®

RIS

MDV Strain CVI 988 :

≥ 4000 pfu/dose

Min.

1000 doses

READ ACCOMPANYING LEAFLET

BIOPROPERTIES PTY LTD

STORE IN LIQUID NITROGEN

APVMA No. 50485/1/1207 LBL-RIS/1 V12

Batch:

Exp:

Label Specifications

Product:

Vaxsafe

RIS Vaccine (living)

Pack size:

1000 doses per ampoule

APVMA LAN:

50485/1/1207

BPL code:

LBL-RIS/1 V12

Label Dimensions:

25 mm h x 33 mm w

Scale (as presented):

100% printed on A4

File name:

50485_40045_1000d_Label_MPL_V1

Label Colours:

1 (black print)

Label Material:

Fasson 2 Mil Clear Printable Polyester

Label Adhesive:

S333/50#SCK ABC

Font Style:

Arial

Font Size:

Line

Point

Type

Horizontal Pane

Bold

Bold

Regular

Regular

Bold

Bold

Bold

Bold

Bold

Regular

Vertical Pane

Regular

Regular

APPROVED

LABEL

Info

pest

Verified

Vaxsafe

RIS Vaccine (living)

50485_40045_2000d_Label_MPL_V1

Page 1 of 1

FOR ANIMAL TREATMENT ONLY

Vaxsafe

®

RIS

MDV Strain CVI 988 :

≥ 4000 pfu/dose

Min.

2000 doses

READ ACCOMPANYING LEAFLET

BIOPROPERTIES PTY LTD

STORE IN LIQUID NITROGEN

APVMA No. 50485/2/1207 LBL-RIS/2 V12

Batch:

Exp:

Label Specifications

Product:

Vaxsafe

RIS Vaccine (living)

Pack size:

2000 doses per ampoule

APVMA LAN:

50485/2/1207

BPL code:

LBL-RIS/2 V12

Label Dimensions:

25 mm h x 33 mm w

Scale (as presented):

100% printed on A4

File name:

50485_40045_2000d_Label_MPL_V1

Label Colours:

1 (black print)

Label Material:

Fasson 2 Mil Clear Printable Polyester

Label Adhesive:

S333/50#SCK ABC

Font Style:

Arial

Font Size:

Line

Point

Type

Horizontal Pane

Bold

Bold

Regular

Regular

Bold

Bold

Bold

Bold

Bold

Regular

Vertical Pane

Regular

Regular

APPROVED

LABEL

Vaxsafe

RIS Vaccine (living)

50485_40045_3000d_Label_MPL_V1

Page 1 of 1

FOR ANIMAL TREATMENT ONLY

Vaxsafe

®

RIS

MDV Strain CVI 988 :

≥ 4000 pfu/dose

Min.

3000 doses

READ ACCOMPANYING LEAFLET

BIOPROPERTIES PTY LTD

STORE IN LIQUID NITROGEN

APVMA No. 50485/3/1207 LBL-RIS/3 V12

Batch:

Exp:

Label Specifications

Product:

Vaxsafe

RIS Vaccine (living)

Pack size:

3000 doses per ampoule

APVMA LAN:

50485/3/1207

BPL code:

LBL-RIS/3 V12

Label Dimensions:

25 mm h x 33 mm w

Scale (as presented):

100% printed on A4

File name:

50485_40045_3000d_Label_MPL_V1

Label Colours:

1 (black print)

Label Material:

Fasson 2 Mil Clear Printable Polyester

Label Adhesive:

S333/50#SCK ABC

Font Style:

Arial

Font Size:

Line

Point

Type

Horizontal Pane

Bold

Bold

Regular

Regular

Bold

Bold

Bold

Bold

Bold

Regular

Vertical Pane

Regular

Regular

APPROVED

LABEL

Vaxsafe

RIS Vaccine (living)

50485_40045_4000d_Label_MPL_V1

Page 1 of 1

FOR ANIMAL TREATMENT ONLY

Vaxsafe

®

RIS

MDV Strain CVI 988 :

≥ 4000 pfu/dose

Min.

4000 doses

READ ACCOMPANYING LEAFLET

BIOPROPERTIES PTY LTD

STORE IN LIQUID NITROGEN

APVMA No. 50485/4/1207 LBL-RIS/4 V12

Batch:

Exp:

Label Specifications

Product:

Vaxsafe

RIS Vaccine (living)

Pack size:

4000 doses per ampoule

APVMA LAN:

50485/4/1207

BPL code:

LBL-RIS/4 V12

Label Dimensions:

25 mm h x 33 mm w

Scale (as presented):

100% printed on A4

File name:

50485_40045_4000d_Label_MPL_V1

Label Colours:

1 (black print)

Label Material:

Fasson 2 Mil Clear Printable Polyester

Label Adhesive:

S333/50#SCK ABC

Font Style:

Arial

Font Size:

Line

Point

Type

Horizontal Pane

Bold

Bold

Regular

Regular

Bold

Bold

Bold

Bold

Bold

Regular

Vertical Pane

Regular

Regular

APPROVED

LABEL

Page: 1 of 2

FOR ANIMAL TREATMENT ONLY

Vaxsafe

®

RIS

Vaccine (living)

Active Constituent:

Each dose contains > 4000 pfu* Marek’s

disease virus (chicken herpesvirus serotype 1) Rispens strain

CVI 988.

*plaque forming units

Statement of Claims:

For the prevention of virulent Marek’s

disease in chickens

.

The vaccine virus has been purified and grown in tissue cultures

derived from specific pathogen free (SPF) eggs.

1000 / 2000 / 3000 / 4000

Doses

Contents:

product

consists

glass

ampoule

vaccine and a plastic container of diluent. Each ampoule of

vaccine contains a minimum of 1000 doses of vaccine. Ampoules

containing 2000, 3000 and 4000 doses are on canes within

cardboard sleeves; the sleeves being labelled with the number of

doses per ampoule. Two hundred (200) mL of diluent is provided

for each 1000 doses of vaccine. The glass ampoule is stored in

liquid nitrogen [approx. -196

C]. The diluent is maintained at

room temperature.

READ DIRECTIONS CAREFULLY

DIRECTIONS FOR USE:

Contraindications:

This product is contraindicated for vaccinating unhealthy

chickens.

Precautions:

place

chickens

contaminated

facilities

adjacent to older chickens.

Exposure to wild-type Marek’s disease virus must be

minimised for at least 3 weeks after vaccination.

Vaccinate all chickens on the premises at one time.

Administer a full dose to each chicken.

Avoid stressful conditions during and following vaccination.

Use entire contents with 1 hr of preparation.

Administer only as directed.

Avoid carcass damage by carefully following instructions

under Method of Vaccination’

Dosage and Administration:

The vaccine is for administration to day-old chickens by

subcutaneous inoculation.

Preparation of vaccine for use:

Read the full instructions and follow them exactly.

Know and follow all precautions and safety practices before

handling liquid nitrogen.

Before

withdrawing

ampoules

from

liquid

nitrogen

vessel, protect hands with leather gloves, wear long sleeves

and protect face and eyes with a plastic face shield or wear

protective

goggles.

Ampoules

that

have

been

cracked

during manufacture or transportation may explode.

Vaccine ampoules are shipped in a vessel that has been

pre-treated with liquid nitrogen. The transport vessel does

NOT contain free liquid nitrogen, but holds the vaccine

below -150

C. Vaccine must be removed from the transport

vessel

IMMEDIATELY

upon

arrival

into

on-site

storage

vessel

that

contains

liquid

nitrogen.

Vaccine

transfer must be carried out as a direct transfer from the

transport vessel into the on-site storage vessel. DO NOT

EXPOSE

VACCINE

ROOM

TEMPERATURE

MORE THAN 10 SEC. Each canister must be at -196

C AT

TIME

TRANSFER

canes.

cardboard

sleeves are present on the vaccine canes, they should be

left in place until immediately prior to use. One cane per

canister is shipped inverted. Vaccine in the tip of inverted

ampoules

indicate

thawing

during

transit.

Contact

BIOPROPERTIES IMMEDIATELY if this occurs.

Mix vaccine in a well-ventilated clean room. Disinfect work

station with alcohol prior to vaccine preparation. Prepare

diluent pack by wiping the rubber stoppers with an alcohol

swab. Match diluent pack with vaccine to be thawed at the

rate of 200 mL per 1000 doses of vaccine. Diluent must be

at room temperature (22-25

C) at the time of use.

Prepare syringe (10 mL) and needle (18 G x 37 mm) using

aseptic technique. Add 3 mL of diluent to the syringe and

replace cap.

Remove from the liquid nitrogen only the ampoules that are

going to be used immediately. (NOTE: remove ampoules in

descending order from each cane; only raise the aluminium

cane

neck

canister

ensure

remaining

ampoules

exposed

room

temperature).

Ampoules removed from liquid nitrogen for more than 30

sec should not be returned to the liquid nitrogen container,

as loss of titre will occur.

Ampoules must be thawed QUICKLY (60-70 sec). Place no

more than 2 ampoules in a large container containing 5-10

L of clean, freshly-prepared water. The water temperature

must be maintained at 27-29

C using a thermostatically

controlled heating element and monitored using a certified

thermometer. Remove gloves, collect the ampoules quickly

and agitate gently during thawing to minimise thaw time.

Avoid inverting ampoules which avoids vaccine entering

lids. When the contents have thawed, remove ampoules

from the thaw bath and wipe dry with clean paper towel.

Remove the lids carefully within the towel by rotating the lids

away from the operator. CAUTION: Fine glass pieces may

be generated during lids removal so ensure eye protection

is in place and ampoule lids are removed within the paper

towel. The broken surface of lid and ampoule are sharp

and should not be touched with fingers or paper to avoid

cutting and contamination.

Add approximately 1 mL of diluent to the open ampoule

before inserting the needle to the bottom of the ampoule

and SLOWLY withdrawing ampoule contents (Note: it is

essential that the vaccine be withdrawn slowly from the

ampoule to minimise damage to the delicate cells contained

within

vaccine.

Cell

destruction

reduces

vaccine

potency).

SLOWLY expel contents into the diluent bottle through the

rubber stopper of the diluent bag. Gently rock the bag

during ejection. Withdraw a further 3 mL of diluent and

gently rinse the inside of each ampoule from the top down.

Eject the rinse back into the diluent bag slowly. Withdraw a

further

diluent

into

syringe

eject

immediately

rinse

syringe.

Thoroughly

prepared vaccine by gently rocking the diluent bag back-

and-forth at least 5-6 times.

The vaccine may be used at room temperature or placed

into an ice bath during use. Ensure all the vaccine is used

within 1 hr after preparation. Agitate the vaccine every 10

min to ensure a uniform suspension of the cells.

Use the vaccine/diluent mixture as described below.

Method of Vaccination:

IMPORTANT:

Sterilise

vaccinating

equipment

autoclaving for a minimum of 15 min at 121

C, or boiling in

water

least

min.

NEVER

allow

chemical

disinfectants to come in contact with vaccinating equipment.

Give subcutaneously only.

Vaccination may be undertaken with a hand-gun syringe or

with an automatic vaccinator.

A sterile automatic hand-gun syringe should be fitted with a

20 G × 25 mm needle that is set to accurately deliver 0.2

APPROVED

LABEL

Page: 2 of 2

mL per dose. Check the accuracy of delivery several times

during the vaccination procedure. Keep needles sharp and

clean by replacing them frequently (approximately every

1000 chickens).

Automatic

vaccinators

should

correctly

disinfected,

assembled and calibrated prior to the commencement of

vaccine

preparation.

Pressure

gauges,

triggers,

vaccine

flow

operation

should

monitored

throughout

vaccination.

Maintain cleanliness at all times.

Dilute

vaccine

only

directed,

observing

precautions and warnings for handling.

Keep the bottle of diluted vaccine in an ice bath if the room

temperature exceeds 27

C and agitate frequently (every 10

min) during use.

Inject chickens subcutaneously into the nape area (under

the loose skin at the back of the neck) just below the head.

The loose skin in this area is raised by gently pinching with

the thumb and forefinger. Insert the needle beneath the skin

in a direction away from the head. Inject 0.2 mL per chicken.

Avoid hitting the muscles and bones in the neck.

Maintain accuracy rather than speed. Staff using automatic

syringes should not exceed 1500 chickens per hour. Staff

using

automatic

vaccinators

should

exceed

3000

chickens per hour otherwise chickens may be missed.

Use the entire contents of vaccine container within one hour

after mixing the vaccine with the diluent.

WITHHOLDING PERIODS: NIL.

USER SAFETY INFORMATION:

Liquid nitrogen precautions:

Only properly trained personnel should handle the liquid nitrogen

containers and vaccines. These persons should be familiar with

AS 1894 - Code of Practice for the Safe Handling of Cryogenic

Fluids

Dangerous

Goods

(Storage

Handling)

Regulations

1989

(S.R.

323/1989).

Liquid

nitrogen

extremely cold. Accidental contact with the skin or eyes can

cause severe frostbite. Protect eyes with goggles or face shield.

Wear

leather

gloves

long

sleeves

when

removing

handling frozen ampoules or when adding liquid nitrogen to the

container. Storage and handling of liquid nitrogen containers

must

well-ventilated

area.

Excessive

amounts

gaseous nitrogen reduces the concentration of oxygen in the air

of an unventilated space and can cause asphyxiation.

Additional information on this product is available on the Material

Safety Data Sheet.

FIRST AID:

Liquid Nitrogen

If drowsiness occurs, get to fresh air quickly and ventilate

the entire area.

If a person becomes groggy or loses consciousness while

working

with

liquid

nitrogen,

person

well-

ventilated area immediately.

If breathing has stopped, begin artificial respiration. Call a

physician immediately.

If poisoning occurs contact a Doctor, or Poisons Information

Centre on 13 11 26

STORAGE INSTRUCTIONS:

Ampoules: Store immersed in liquid nitrogen.

Diluent: Store at room temperature.

Liquid nitrogen container: Carefully observe all liquid nitrogen

precautions including wearing eye protection and leather gloves.

Store in a cool, well-ventilated area. Check liquid nitrogen level

daily. Keep container away from incubator intakes and chicken

holding boxes.

DISPOSAL:

Discarded unused vaccine and empty vaccine bottles into a

disinfectant solution (e.g. chlorine-based bleach). Dispose of any

such

inactivated,

unused

vaccine

empty

containers

wrapping in paper and putting in garbage.

In cases of spillage, soak up the liquid with an absorbent sponge

or cloth and incinerate. Treat the surface with a disinfectant

solution (e.g. chlorine-based bleach).

CAUTION:

The capability of this vaccine to produce satisfactory results

depends upon many factors, including – but not limited to –

conditions of storage and handling by the user, administration of

the vaccine, health and responsiveness of individual chickens

and timing/degree of field exposure. Therefore, directions for

use should be followed carefully.

CONTACT DETAILS:

BIOPROPERTIES Pty Ltd

ACN 007 303 728

36 Charter Street

Ringwood

Victoria 3134, Australia

PH: 03 9876 0567 FAX: 03 9876 0556

WARRANTY AND DISCLAIMER

Vaxsafe

RIS has been tested and meets safety and potency

standards according to the Standards required by the APVMA.

BIOPROPERTIES Pty Ltd accepts no responsibility for events

arising

from

misuse

mishandling

product.

BIOPROPERTIES Pty Ltd gives no warranty (express or implied)

with

respect

product,

including

without

limitation

warranty as to completeness, merchantability or fitness for a

particular

purpose.

Under

circumstances

shall

BIOPROPERTIES

liable

indirect,

special,

consequential or punitive damages.

APVMA No: 50485/1207

Code/Version No: LFT-RIS V12

APPROVED

LABEL

MSDS -

MaterialSafetyData Sheet

Vaxsafe ®

RIS Vaccine(living)

BIOPROPERTIESPtyLtd Page1of5 DateofIssue:December2011

MSDS-RISV5

BIOPROPERTIESPty.Ltd.

ACN007303728

36CharterStreet Telephone: 03 9876 0567

Ringwood VIC 3134 Facsimile: 03 9876 0556

AUSTRALIA Emergency: 0417 548 879

WORKHAZARDASSESSMENT

The vaccine isnotclassified as hazardous tohealthaccordingtocriteriaofWorksafe Australia.

Note:Thisproductisstoredinliquidnitrogenwhichcancausefrostbiteandremoveairfromenclosed

spaces.Beforeworkingwiththevaccineitisimportanttobecomefullyfamiliarwiththesafeuseand

handlingofliquidnitrogen –seeAS1894-1976CodeofpracticeforthesafehandlingofCryogenic

Fluids, andstudyitsMSDS.

PRODUCTIDENTIFICATION

Product Name:Vaxsafe ®

RISVaccine(living)

OtherNames:Rispens Vaccine, Mareks vaccine.

Product Code:9503RIS

APVMANo:50485

UN Number:Noneallocated.

Dangerous Goods

Class/SubsidiaryRisk:Noneallocated.

Hazchem Code:Noneallocated.

Poisons Schedule

Number:Noneallocated.

Product Type:Poultryvaccine

Chemical Family:Theactiveingredientconsistsofanavianherpesvirusinaprotective

buffer.

Use:AsavaccinetocontrolMarek’sDisease in chickens.

MethodofUse:Givenbyinjectiontoday-old chicks.

PHYSICALDESCRIPTIONANDPROPERTIES

Appearance:Frozen,palepinkorstraw-colouredliquidinalabelled,sealedclear-glass

ampoule-stored in liquid nitrogen.

MeltingPoint:Not relevant.

BoilingPoint:Not relevant.

VapourPressure:Not relevant.

Volatile Materials:Not available.

SpecificGravity:Not relevant.

Flashpoint:Not relevant.

FlammabilityLimits:Not relevant.

Solubilityin Water:Fullymiscible.

pH:Not available.

MSDS -

MaterialSafetyData Sheet

Vaxsafe ®

RIS Vaccine(living)

BIOPROPERTIESPtyLtd Page2of5 DateofIssue:December2011

MSDS-RISV5

INGREDIENTS

WorksafeExposure Limits

Chemical Name CAS# Proportion

ByVolume TWA

mg/m 3

ES-STEL

mg/m 3

Mareksdisease virus, RispensStrain,living,

in SPF*chickenembryo cellssuspendedin a

buffer ofingredientsdetermined nottobe

hazardous(includinganimaltissue

components). None

allocated 96.25% None

allocated None

allocated

DimethylSulfoxide(DMSO) 67-68-5 3.75% Not set Not set

*SPF=SpecificPathogenFree.

Thisisacommercialproduct andthe exact ratio ofcomponentsmayvary. Trace quantitiesofimpurities

are also likely.

HEALTHHAZARDINFORMATION

HEALTHEFFECTS

Acute:No evidence for humans.

Swallowed:No evidence for humans.

Eye:No evidence for humans.

Skin:Possible mild irritationwithredness, itchingand urticarialwheals.

Inhaled:Not relevant.

Chronic:No evidence for humans.

Injection:Needlestickinjuriescanoccurwhenmanualvaccinationtechniquesare

used.Resultantinjuriesareduetotheeffectsofthepenetrationofthe

needle,itscleanlinessatthetimeofpenetration,thevolumeinjected,and

possiblysomeeffectduetothepresenceofDMSOintheinoculum.The

inoculumitselfisnotregardedastoxic(beinginjectedintoday-oldchicks

aspart ofnormalvaccinationprocedures).

FIRST AID

Swallowed:Rinsemouthwithclean,freshwaterandswallowsomecleanwater.If

symptomsappear, seed medicaladvice.

Eye:Holdeyesopenandgentlywashmaterialfromthemwithcleanrunning

water.Ensureirrigationundereyelidsbyliftingthem.Donotattemptto

removecontactlensesunlesstrainedtodoso.Ifirritationoccurs,seek

medicaladvice.

Skin:Washaffectedareawithsoapandcoldwater.Ifirritationoccurs,seek

medicaladvice.

Inhaled:Directinhalationisnotrelevant.Ifinhaledaftergenerationofamist,

removepersontofreshairandobserveuntilrecovered.Ifirritationor

other symptomspersist, seekmedicaladvice.

Injection:Washthewoundundercleanrunningwater,coverthewoundwitha

band-aidtostopanypenetrationofdirtandseekmedicalorparamedical

advice astothe extent ofthe tissuedamaged.

First Aid Facilities:No specialfacilitiesare required.

ADVICETODOCTOR:

TheproductcontainslowlevelsofDMSOwhichcanactasacarrieracrosscellmembranes.Itcontains

animalproteinsthatcouldcauseallergicreactions.Apartfromthevaccineitselfanyviable

microorganismspresent would have gained accessatthetime ofexposure.

MSDS -

MaterialSafetyData Sheet

Vaxsafe ®

RIS Vaccine(living)

BIOPROPERTIESPtyLtd Page3of5 DateofIssue:December2011

MSDS-RISV5

PoisonsInformationCentre:131126(anywhere in Australia)

PRECAUTIONSFORUSE

Exposure Standards: Notimeweightedaverage(TWA)hasbeenset.Thereisablanket

recommendationof10mg/m 3

forinhalabledustsormistswhenlimits

havenototherwisebeenestablished.Thenatureofthisproductmakesit

unlikelythatthislevelwillbeapproached in normaluse.

EngineeringControls: InnormaluseconcentrationsshouldbewellbelowtheTWAvalue.If

necessary,valuesmaybereducedbyprocessmodification,useoflocal

exhaustventilation,capturingsubstancesatthesource,orother

methods.Ifyoubelieveairborneconcentrationsofmists,dustsor

vapoursarehigh,youareadvisedtomodifytheprocessorenvironment

toreduce theproblem.

SegregationofProcesses

from Personnel: Storetheproductandallcontainersofliquidnitrogeninastoragearea

that isbothwell-ventilated andwellawayfromstaff.

MechanicalHandling:Use onlyapprovedequipment andprocesses.

Capture ofSubstances at

SourceandDisposal with

Local Exhaust Ventilation: Liquidnitrogen:thestorageareamustbewellventilatedsoastoremove

thegasgeneratedtoexternalairwithoutallowingittopenetrateconfined

areas. Provideadequatelocalexhaust anddilutionventilation.

DilutionVentilation:Liquidnitrogen:ventilationshouldbesuchthatthereisaplentifulback-up

supplyoffresh airtothe storagearea.

PersonalProtection:

RespiratorType:Providedtheoperatorisworkinginawell-ventilatedarea,arespiratoris

notnecessary.Donotworkwithliquidnitrogeninsmall,poorly-ventilated

areaswithoutairdrainageatfloorlevel.

Glove Type:Wearglovesdesignedforuseinfreezersanduseforcepstohandlethe

product.Glovesdonotallowthewearertoimmerse anypart ofhisor her

handsin liquid nitrogen.

Eye Protection:Wearapolycarbonatefaceshieldtoprotectagainstbothsplashandthe

shatteringofampoules.

Clothing:Wearoveralls(seeAS2919)andbootscapableofprotectingagainst

penetrationofliquids(seeAS/NZS2210-OccupationalProtective

Footwear).

Other:Earplugsormuffsshouldbewornwhenremovingampoulesfromliquid

nitrogen,asanexplodingampoulemaycausehearinglossand/or

“ringing”in theears.

Alwayswash yourhandsafter usingthe product.

Removecontaminatedclothingwithoutdelayandwashitandother

personalprotective equipment before storingor re-use.

Flammability:

Fire Hazards:Non-flammable.

Sources ofIgnitionAdvice:Notrelevant.

MSDS -

MaterialSafetyData Sheet

Vaxsafe ®

RIS Vaccine(living)

BIOPROPERTIESPtyLtd Page4of5 DateofIssue:December2011

MSDS-RISV5

SAFEHANDLINGINFORMATION

Storage andTransport:

Location:Storetheproductandallcontainersofliquidnitrogeninacool,dry,well

ventilatedareathatissegregatedfrompersonnelandoutofdirect

sunlight.

Security:Keep in asecure place withrestrictedaccessand awayfromchildren.

Ventilation:Alwayskeepcontainerswithliquidnitrogeninwell-ventilatedareasthat

allowescapeofgasgivenoff(providedrainsatfloorlevel)andnever

within enclosedspacessuch asthe cabin ofavehicle.

Type of

Container/Package: A2mLheat-sealedglassampoulewithclearlabel,storedinliquid

nitrogenonanaluminiumcane.

SpecialTransport

Requirements: Keepinwell-ventilatedareasatalltimes,neverwithinthedriving

compartment.

SpillsandDisposal:

CleanUpSpills/Leaks:Allowtheliquidnitrogentoevaporate,treattheareawithdisinfectantand

thenmopupallremainingliquids.Intheunlikelyeventofmajorrunoff,

adviseemergencyservicesifasignificantquantityofmaterialenters

drains.

Precautions for

CleanUpCrew: Becarefulnottoexposeyourselftoliquidnitrogenandtakecarethatthe

area iswell-ventilated.

Disposal Method:Mopupliquidsandsweepupbrokencontainers.Disposeofsolidwaste

bywrappinginpaperpriortodisposalincompliancewithlocal,Stateand

Federalregulations.

Fire andExplosionHazard:

Hazards ofUse/Storage:Liquidnitrogen:crackedorimproperly-sealedampouleswhenplacedin

liquidnitrogencancauseleakageofliquidnitrogenintotheampoule.

Whenremovedfromstoragetherapidriseinpressurecausedbythe

changefromliquidtogaseousnitrogencancausetheampouleto

explode.

List ofDangerous

Decompositionor

CombustionProducts:Not available.

Fire-fighting

Recommendations:Not relevant.

Typesof

Extinguisher/Fire-fighting

Agents:Not relevant.

Precautions:Not available.

Protective Clothing:Seeabove,underPersonalProtection.

Reactivity:Not relevant.

HazchemCode:Noneallocated.

MSDS -

MaterialSafetyData Sheet

Vaxsafe ®

RIS Vaccine(living)

BIOPROPERTIESPtyLtd Page5of5 DateofIssue:December2011

MSDS-RISV5

OTHERINFORMATION

ThisMSDShasbeenpreparedin accord withtheWorksafe Australia "NationalCode for Preparation

ofMaterialSafetyDataSheets", 1994

CONTACTPOINT

Title:

Technical&MarketingManager

BIOPROPERTIESPtyLtd

ACN 007303 728

36Charter Street

Ringwood

Victoria 3134,Australia

Australia International

Telephone:03 9876 0567 +61398760567

Facsimile:03 9876 0556 +61398760556

Emergency

Telephone: 0417 548 879 +61417 548 879

Email:chris.morrow@bioproperties.com.au

READ ALLLABELSAND INSTRUCTION LEAFLETSBEFOREUSINGTHISPRODUCT

WARRANTYAND DISCLAIMER:

TothebestofBIOPROPERTIES ’knowledgethehealth,safetyandhandlinginformationinthisMSDSisaccurateatthedate

hereof.BIOPROPERTIESassumesnoresponsibilityreg ardingthesuitabilityofthisinformationfortheuser’sintendedpurposes

orfortheconsequenceofsuchuse.Iffurtherinformationisrequiredtoensureanappropriateriskassessmentismade,theuser

shouldcontactBIOPROPERTIES.BIOPROPERTIESgivesnowarranty(expressorimplied)withrespecttothisMSDSorthe

product,includingwithoutlimitationanywarrantyastocompleteness,merchantabilityorfitnessforaparticularpurpose.Under

nocircumstancesshallBIOPROPERTIESbeliableforindirect,special,consequentialorpunitivedamages.

Similar products

Search alerts related to this product

View documents history

Share this information